Found: 26
Select item for more details and to access through your institution.
An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 971, doi. 10.1007/s00280-011-1617-9
- By:
- Publication type:
- Article
Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 985, doi. 10.1007/s00280-010-1393-y
- By:
- Publication type:
- Article
Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 995, doi. 10.1007/s00280-010-1395-9
- By:
- Publication type:
- Article
The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1007, doi. 10.1007/s00280-010-1390-1
- By:
- Publication type:
- Article
H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1017, doi. 10.1007/s00280-010-1397-7
- By:
- Publication type:
- Article
Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1027, doi. 10.1007/s00280-010-1399-5
- By:
- Publication type:
- Article
Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1035, doi. 10.1007/s00280-010-1402-1
- By:
- Publication type:
- Article
Tanespimycin pharmacokinetics: a randomized dose-escalation crossover phase 1 study of two formulations.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1045, doi. 10.1007/s00280-010-1398-6
- By:
- Publication type:
- Article
Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1055, doi. 10.1007/s00280-010-1400-3
- By:
- Publication type:
- Article
Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1063, doi. 10.1007/s00280-010-1396-8
- By:
- Publication type:
- Article
Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1073, doi. 10.1007/s00280-010-1408-8
- By:
- Publication type:
- Article
Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1085, doi. 10.1007/s00280-010-1409-7
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, by twice daily oral administration between meals in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1101, doi. 10.1007/s00280-010-1404-z
- By:
- Publication type:
- Article
Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1111, doi. 10.1007/s00280-010-1322-0
- By:
- Publication type:
- Article
Phase I, pharmacokinetic, and biological studies of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, administered after meals with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1119, doi. 10.1007/s00280-010-1405-y
- By:
- Publication type:
- Article
Rapamycin suppresses ROS-dependent apoptosis caused by selenomethionine in A549 lung carcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1129, doi. 10.1007/s00280-010-1417-7
- By:
- Publication type:
- Article
Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1137, doi. 10.1007/s00280-010-1420-z
- By:
- Publication type:
- Article
A combined pharmacokinetic model for the hypoxia-targeted prodrug PR-104A in humans, dogs, rats and mice predicts species differences in clearance and toxicity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1145, doi. 10.1007/s00280-010-1412-z
- By:
- Publication type:
- Article
Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1157, doi. 10.1007/s00280-010-1418-6
- By:
- Publication type:
- Article
Sulforaphane potentiates oxaliplatin-induced cell growth inhibition in colorectal cancer cells via induction of different modes of cell death.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1167, doi. 10.1007/s00280-010-1413-y
- By:
- Publication type:
- Article
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1179, doi. 10.1007/s00280-010-1466-y
- By:
- Publication type:
- Article
The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects?
- Published in:
- 2011
- By:
- Publication type:
- Letter
In reply.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1193, doi. 10.1007/s00280-010-1535-2
- By:
- Publication type:
- Article
A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1203, doi. 10.1007/s00280-010-1538-z
- By:
- Publication type:
- Article
Erratum to: Reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104 in mice.
- Published in:
- 2011
- By:
- Publication type:
- Correction notice